Utilizing an external artificial pancreas is more effective in improving glucose control and reducing the risk of hypoglycemia than currently available conventional diabetes treatments, a new study reveals.
According to scientists, the external artificial pancreas is an automated system that simulates the normal pancreas by continuously adapting insulin delivery based on changes in glucose levels.
Two configurations exist: the single-hormone artificial pancreas that delivers insulin alone and the dual-hormone artificial pancreas that delivers both insulin and glucagon. While insulin lowers blood glucose levels, glucagon has the opposite effect and raises glucose levels.
The study was published in The Lancet Diabetes and Endocrinology.